Skip to main content

Medicare copays for new Alzheimer's drug could reach $11,500 annually

By NPR / Associated Press  
   June 11, 2021

A new $56,000-a-year Alzheimer's drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, according to a research report published Thursday.

Full story

Get the latest on healthcare leadership in your inbox.